Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07770243). This is a study registration, not published results. Lead sponsor: Hong Kong Metropolitan University. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 36 participants (ESTIMATED). Conditions: Breast Cancer, Cancer Survivorship. Interventions: BEHAVIORAL: AIMS platform. Primary outcome measures: Recruitment rate , From recruitment commencement until completion of recruitment.; Participant retention at Week 12 , Week 12; Adherence to the AIMS intervention , Weekly during Weeks 1-12, summarized at Weeks 4 and 12.; Acceptability and usability of the AIMS platform , Weeks 4 and 12.. Brief summary: This pilot randomized controlled trial will test the feasibility and acceptability of an Artificial Intelligence-based Multidimensional Symptom Management (AIMS) intervention for post-treatment breast cancer survivors. Thirty-six participants will be randomly assigned (1:1) to receive either the AIMS intervention or usual care. Outcomes include feasibility (recruitment and retention), adherence, acceptability, symptom burden, psychological distress, quality of life, and safety of the AIMS intervention.